Yarrow Bioscience, Inc. (YARW) insider trading.
In Q3 2026, insiders at Yarrow Bioscience, Inc. reported 9 non-derivative transactions on 23 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 9
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 5
- Last filed
- 2026-07-30
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Stuart Iain | Officer · CHIEF SCIENTIFIC OFFICER | 2 | 0 | 0 |
| Domzalski David | Director, Officer · PRESIDENT AND CEO | 2 | 0 | 0 |
| Harsch Mutya | Officer · CHIEF LEGAL OFFICER AND GC | 2 | 0 | 0 |
| Zeronda Tyler | Officer · CHIEF FINANCIAL OFFICER | 2 | 0 | 0 |
| WONG RODERICK / RTW Fund Group GP, LLC | TenPercentOwner | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-07-29 | WONG RODERICK / RTW Fund Group GP, LLC | J (D) | 133,290 | $0 | 266,307 | Form 4 |
| 2026-07-23 | Stuart Iain | F (D) | 15,405 | $0.9 | 95,944 | Form 4 |
| 2026-07-23 | Domzalski David | F (D) | 79,391 | $0.9 | 347,174 | Form 4 |
| 2026-07-23 | Harsch Mutya | F (D) | 22,516 | $0.9 | 95,918 | Form 4 |
| 2026-07-23 | Zeronda Tyler | F (D) | 22,516 | $0.9 | 74,918 | Form 4 |
| 2026-06-30 | Stuart Iain | F (D) | 2,370 | $0.65 | 111,349 | Form 4 |
| 2026-06-30 | Domzalski David | F (D) | 12,214 | $0.65 | 426,565 | Form 4 |
| 2026-06-30 | Harsch Mutya | F (D) | 3,464 | $0.65 | 118,434 | Form 4 |
| 2026-06-30 | Zeronda Tyler | F (D) | 3,464 | $0.65 | 97,434 | Form 4 |
Transaction codes in this quarter
Get YARW insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1566044&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · YARW company page · Yarrow Bioscience, Inc. on SEC.gov
Questions
Are insiders buying or selling Yarrow Bioscience, Inc. (YARW)?
In Q3 2026, insiders at Yarrow Bioscience, Inc. reported 9 non-derivative transactions on 23 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Yarrow Bioscience, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/yarw.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.